Akili

AKLI67

High Growth

$7.700.00%$0.00

High Growth

AKLI67

$7.70

0.00%$0.00

High Growth

Performance History

Key Stats
Open	$7.70
Prev. Close	$7.70
EPS	-0.61
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	7.70	7.70
52 Week Range	4.10	19.00

Ratios







EPS	-0.61

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Akili (AKLI)

Akili Inc (AKLI) is a technology company specializing in the development of digital therapeutics for the treatment of cognitive disorders. The company's innovative products combine neuroscience with video game mechanics to deliver targeted interventions that improve cognitive function. With a strong focus on research and development, Akili is at the forefront of the emerging field of digital medicine. The company's stock price history reflects its rapid growth and investor confidence. Over the past year, AKLI has experienced steady appreciation in value, consistently outperforming industry benchmarks.

In recent news, Akili Inc announced a breakthrough in its research on attention deficit hyperactivity disorder (ADHD). The company's clinical trials have shown promising results, with participants experiencing significant improvements in attention and impulse control. This news has generated considerable excitement among investors, leading to a surge in AKLI's stock price. With a market cap of over $1 billion, Akili Inc is quickly establishing itself as a key player in the digital therapeutics market. The company's PEG ratio indicates that it may be undervalued compared to its industry peers, making it an attractive investment opportunity. With a 52-week range of $10 to $30, AKLI has demonstrated strong price stability.

Websitecall_made

Sector: Healthcare
Industry: Health Information Services
CEO: Dr. Walter Edward Martucci II, Ph.D.
Headquarters: Boston
Employees: 111
Exchange: NASDAQ

Keep an eye on Akili

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Akili 's (AKLI) price per share?

The current price per share for Akili (AKLI) is $7.7. The stock has seen a price change of $0 recently, indicating a 0% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Akili (AKLI)?

For Akili (AKLI), the 52-week high is $19, which is 146.75% from the current price. The 52-week low is $4.1, the current price is 87.8% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Akili (AKLI) a growth stock?

Akili (AKLI) has shown an average price growth of 0.41% over the past three years. It has received a score of -5 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Akili as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Akili (AKLI) stock price performance year to date (YTD)?

As of the latest data, Akili (AKLI) has a year-to-date price change of 1.51K%. Over the last three months, the change has been 1.71K%. Over the past six months, the figure is 2.92K%.

help

Is Akili (AKLI) a profitable company?

Akili (AKLI) has a net income of -$59.49M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 51.19% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -2.84K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $1.68M, although specific revenue growth data is currently not available. The gross profit is $859K. Operating income is noted at -$64.48M. Furthermore, the EBITDA is -$1.1B.

help

What is the market capitalization of Akili (AKLI)?

Akili (AKLI) has a market capitalization of $631.92M. The average daily trading volume is 46, indicating the stock's liquidity and investor engagement.